The whistleblower had alleged that Sun Pharma's distributor Aditya Medisales Ltd had transactions worth more than 58 billion rupees ($814 million) with Suraksha Realty, controlled by the executive director, Sudhir Valia, a report by Moneylife magazine said. Sun Pharma said it had not received the complaint and was not privy to contents of the document. Sun Pharma said on Tuesday it replaced Aditya Medisales with its wholly owned unit as the new distributor for its domestic formulations business.
INDIA TOP NEWS • India sacks PNB executives for lapses in $2 billion fraud in first firings -sources India has sacked two executives of state-run Punjab National Bank for allegedly failing to prevent a $2 billion fraud, two sources said on Sunday, nearly a year after the country's biggest bank scam came to light and also dragged the government into the controversy. • SBI says lenders awaiting SEBI decision on Etihad offer for Jet Airways - paper The State Bank of India (SBI)-led consortium of lenders is waiting for India’s capital markets regulator to decide on a bailout offer by ...
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...
(Reuters) - Sun Pharmaceutical Industries Ltd on Friday asked India's capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company's ...
Sun Pharmaceutical Industries Ltd on Friday asked India's capital markets regulator to look into a media report about an alleged complaint by a whistleblower that led to a sell-off in the company's shares. ...
Shares of the nation’s largest drugmaker slipped 8.4 percent to close at 390.75 rupees a share -- the lowest level since March 2013. Sun Pharma was the day’s worst performer on S&P BSE Sensex, data compiled by Bloomberg shows.
(Reuters) - Indian shares finished a touch higher on Friday, as earnings-driven gains in oil-to-retail conglomerate Reliance Industries Ltd helped offset sharp losses in Sun Pharmaceutical Industries Ltd. ...
The complaint, sent to capital market regulator Securities and Exchange Board of India (SEBI), is the second in over a month and comes as Sun Pharma already battles a product recall and regulatory investigation over reported insider trading. The whistleblower alleged in a 172-page complaint that Sun Pharma's distributor Aditya Medisales had transactions worth more than 58 billion rupees ($815 million) with Suraksha Realty, controlled by Sun's co-promoter Sudhir Valia, a report by Moneylife magazine said. Sun Pharma's payment to Aditya Medisales was transferred to the promoter and group ...
The complaint, sent to capital market regulator Securities and Exchange Board of India (SEBI), is the second in over a month and comes as Sun Pharma already battles a product recall and regulatory investigation over reported insider trading. The whistleblower alleged in a 172-page complaint that Sun Pharma's distributor Aditya Medisales had transactions worth more than 58 billion rupees ($815 million) with Suraksha Realty, controlled by Sun's co-promoter Sudhir Valia, a report by Moneylife magazine said. Sun Pharma's payment to Aditya Medisales was transferred to the promoter and group ...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Read More...
The private sector bank will now seek approval from the Reserve Bank of India (RBI) for the CEO appointment, and will make the relevant disclosures after the RBI's approval, the lender said in a statement. Yes Bank's governance was thrown into question in September when the RBI asked Kapoor to step down by the end of January, sending its stock plunging and causing several resignations from its board.
Indian telecom company Reliance Communications Ltd (RCom) said it remained "fully committed" to settle dues with Swedish telecom gearmaker Ericsson from the proceeds of its sale of wireless assets to Reliance Jio Infocomm Ltd. "RCom has taken all required steps towards enabling the settlement and remains fully committed to make the payment to Ericsson from the proceeds of the spectrum sale," it said in a clarification filed to the exchanges on Sunday. It had not received any contempt petition from Ericsson, it added.
The share prices of the top two gainers on the MSCI Asia Pacific Index have more than tripled this year and seven others have doubled their stock values. “As it is, 2018 has been pretty eventful,” said Christina Woon, Asian equities investment manager at Aberdeen Standard Investments in Singapore. The so-called multibaggers in Asia may underscore the “bottom up” approach to stock selection amid volatility caused by the U.S-China trade war and Federal Reserve’s interest-rate hikes.
MUMBAI, India and PRINCETON, New Jersey , December 26, 2018 /PRNewswire/ -- DUSA Pharmaceuticals, Inc., ("DUSA"), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO) ...
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we'll show how The South Indian Bank Limited's Read More...
Prabhat Dairy Limited (NSE:PRABHAT) is a company with exceptional fundamental characteristics. Upon building up an investment case for a stock, we should look at various aspects. In the case of Read More...
Dividends play a key role in compounding returns over time and can form a large part of our portfolio return. Historically, Ashok Leyland Limited (NSE:ASHOKLEY) has paid dividends to shareholders, Read More...
Jio informed the DoT that it won't be held liable for RCom's past dues related to airwaves, according to the report. The plan to sell the assets had followed a settlement with telecom gearmaker Ericsson for partial payment of dues owed by RCom to the Swedish company. RCom shares, which traded at 14.5 rupees by 0428 GMT, have more than halved in value this year, as of last close.
